Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Organon & Co. (OGN) CEO Kevin Ali Presents at 42nd Annual Cowen Health Care Conference (Transcript)
10:51am, Wednesday, 09'th Mar 2022
Organon & Co. (OGN) CEO Kevin Ali Presents at 42nd Annual Cowen Health Care Conference (Transcript)
New Upgrade: Organon & Co Stock Shows Rising Relative Strength
06:12pm, Wednesday, 02'nd Mar 2022 Investor''s Business Daily
Organon & Co sees its Relative Strength Rating enter the elite 90-plus level.
Organon To Present at the Cowen 42nd Annual Healthcare Virtual Conference
12:00pm, Wednesday, 02'nd Mar 2022 Business Wire
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Cowen 42nd Annual Healthcare Virtual Conference on Wednesday, March 9, 2022 at 9:10 a.m. EST. Investors, analysts, members of the media and the general public are invited to watch to a live video webcast of the presentation at https://www.organon.com/investor-relations/events-and-prese
Organon To Present at the Cowen 42nd Annual Healthcare Virtual Conference
07:00am, Wednesday, 02'nd Mar 2022
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in
The 2 Best ETFs for Dividends
02:45pm, Monday, 28'th Feb 2022 The Motley Fool
These two ETFs are built to deliver the most dividend income possible
Organon Shares Up About 7% Since Merck Spinoff
02:51pm, Thursday, 24'th Feb 2022
Shares of Organon & Co. ( OGN , Financial) are up nearly 7% since the pharma company was spun off by Merck & Co. Inc. ( MRK , Financial) in the middle of 2021. And even bluer skies appear to be on the
Viatris Vs. Organon: Surprisingly Undervalued, But Which Is The Better Buy?
05:57am, Saturday, 19'th Feb 2022
Viatris was formed by the merger of Pfizer's Legacy Brands business Upjohn with generic drug developer Mylan.
Organon & Co. (OGN) CEO Kevin Ali on Q4 2021 Results - Earnings Call Transcript
06:19pm, Thursday, 17'th Feb 2022 Seeking Alpha
Organon & Co. 2022 Q4 - Results - Earnings Call Presentation
04:47pm, Thursday, 17'th Feb 2022 Seeking Alpha
Merck Spinoff Organon Beats Quarterly Views, But Offers Dim Guidance
02:03pm, Thursday, 17'th Feb 2022 Investor''s Business Daily
Organon topped fourth-quarter estimates Thursday, but OGN stock fell on lighter-than-expected 2022 sales guidance.
Organon & Co. (OGN) CEO Kevin Ali on Q4 2021 Results - Earnings Call Transcript
01:19pm, Thursday, 17'th Feb 2022
Organon & Co. (OGN) CEO Kevin Ali on Q4 2021 Results - Earnings Call Transcript
Established Brands Hit Organon''s Q4 Sales, Expects FY22 Sales Of Upto $6.4B
12:47pm, Thursday, 17'th Feb 2022 Benzinga
Organon & Co''s (NYSE: OGN ) Q4 FY21 sales decreased 1% to $1.6 billion , beating the consensus of $1.57 billion. Women''s Health increased 6%, driven primarily by Nexplanon, which increased 37% ex-FX. Nexplanon''s growth was due to increased demand in the U.S., and tenders won. The increase in Women''s Health was partially offset by a decline … Full story available on Benzinga.com
Organon declares $0.28 dividend
12:38pm, Thursday, 17'th Feb 2022 Seeking Alpha
Organon (OGN) declares $0.28/share quarterly dividend, in line with previous…......................
Organon projects in-line guidance for 2022 as topline and bottom-line contract
12:28pm, Thursday, 17'th Feb 2022 Seeking Alpha
Organon (OGN) set its 2022 revenue in line with Wall Street forecasts even as the contraction in its topline and the bottom line continued for another quarter in Q4 2021
Organon Non-GAAP EPS of $1.37 beats by $0.10, revenue of $1.6B beats by $20M
11:31am, Thursday, 17'th Feb 2022 Seeking Alpha
Organon press release (OGN): Q4 Non-GAAP EPS of $1.37 beats by $0.10.Revenue of $1.6B (-0.6% Y/Y) beats by $20M.FY22 Guidance:Revenue of $6.1-$6.4B vs
